Navigation Links
UNIAPAC Foundation Think Tank in Paris selects Renova Therapeutics CEO and Co-founder as keynote speaker for annual meeting

SAN DIEGO, March 7, 2017 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes, today announced that the company's CEO and Co-founder, Jack W. Reich, Ph.D., has been selected as a keynote speaker for the prestigious UNIAPAC Foundation Think Tank meeting on March 17, 2017, in Paris.

The aim of this annual meeting is to lead a candid and open debate among academics, business leaders and distinguished guests, to provide insights on the main socioeconomic challenges of the 21st century. The meeting brings together 24 high-level attendees and includes a full set of presentations and dialogue sessions.

Dr. Jack W. Reich, CEO & Co-founder of Renova Therapeutics
Dr. Jack W. Reich, CEO & Co-founder of Renova Therapeutics
 (PRNewsFoto/Renova Therapeutics)
(PRNewsFoto/Renova Therapeutics)...

A pioneer in the field, Dr. Reich will be speaking on the social, economic and healthcare delivery implications of gene therapy.

"I'm honored to engage on the topic of gene therapy with bright minds who are dedicated to finding solutions to some of the world's greatest challenges," says Dr. Reich. "Our mission at Renova Therapeutics – to create transformational therapies that treat the world's most prevalent diseases – fits closely with the goals of UNIAPAC and its foundation. We're focused on treating chronic diseases that have a debilitating impact on hundreds of millions of people worldwide – and doing so by potentially reversing the disease process, rather than treating symptoms. Diminishing these major threats to global health would have tremendous socioeconomic impact."

Founded in 1931, UNIAPAC is an ecumenical union that groups together Christian Business Leader associations in 40 countries in Europe, Latin America, Africa and Asia. UNIAPAC represents more than 30,000 active business executives working in various leading sectors of the world economy. The organization's goal is to promote a vision and deployment of Corporate Social Responsibility focused on the human person, with a view of bringing about change in business attitudes toward more responsible and sustainable economic, social and human progress.

The UNIAPAC Foundation was created in 2010 with the intent to actively assist UNIAPAC National Associations in their local initiatives and support their activities at an international level. The foundation is a key facilitator in UNIAPAC's continuous dialogue with all men and women of goodwill who are interested in ensuring the rightful place of the human person in the economy.

Dr. Reich will lead one of four panels at the foundation's think tank meeting.

About Renova Therapeutics
Renova Therapeutics is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. The first indications the company is pursuing are gene therapy treatments for congestive heart failure (CHF) and type 2 diabetes, two of the most common and devastating chronic diseases in the world. The company's lead product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in millions of patients with CHF. The company's product pipeline also includes a groundbreaking gene therapy in preclinical stage for sufferers of type 2 diabetes, as well as a peptide infusion therapy for the treatment of acute decompensated heart failure. Renova Therapeutics was founded in 2009 and is led by an experienced management team in biopharmaceuticals and gene therapy. For additional information about the company, please visit


To view the original version on PR Newswire, visit:

SOURCE Renova Therapeutics
Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. UCB, Inc. and the Epilepsy Foundation of Georgia Launch EFWorks to Help Georgians with Epilepsy Find Employment
2. New Jersey Health Foundation Awards $1.1 Million to Advance Research Throughout NJ
3. Foundation for Food and Agriculture Research Seeks Early Career Nominees for New Innovator in Food and Agriculture Research Award
4. Foundation for Food and Agriculture Research Congratulates Edward Buckler, First Recipient of Prestigious NAS Prize for Extraordinary Contribution to Food and Agriculture
5. Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical Trial for Pancreatic Cancer
6. Symbios Announces National Science Foundation SBIR Phase IIB Award to Commercialize Plasma Oxidation Technology
7. ACRES and Task Force Dagger Foundation Partner to Improve Special Operations Forces Health
8. Thanks to Tesoro Foundation, South Texas Blood & Tissue Center can roll out new bus
9. Rockland Immunochemicals, Inc. Partners with Alex’s Lemonade Stand Foundation to Support Early Career Childhood Cancer Researchers
10. St. Baldricks Foundation Sets $50,000 Goal for Giving Tuesday Fundraising Challenge
11. Foundation for Food and Agriculture Research Opens Seeding Solutions Funding Opportunity: $7 Million Available for Bold Science Addressing Food and Agriculture Challenges
Post Your Comments:
(Date:8/31/2018)... ... August 29, 2018 , ... A recent expedition led ... and the Institute of Industrial Science, the University of Tokyo, demonstrated how the ... exploration and study of hard to reach deep sea ecosystems, like intermittently active ...
(Date:8/29/2018)... ... August 28, 2018 , ... Inc. Magazine has announced that ... in 1138th place on the 27th annual Inc. 5000, the most prestigious ranking ... most successful companies within the American economy’s most dynamic segment – independent small ...
(Date:8/26/2018)... ... August 23, 2018 , ... ... innovators, engineers, and scientists from around the world, will host the 4th Annual ... an array of industries and disciplines, encompassing various research areas including medicine, agriculture, ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... in medical device compliance and commercialization, has just released a new paper ... and presented by Dr. Mario Kossmann, ESEP at the 28th Annual INCOSE ...
Breaking Biology Technology:
(Date:9/7/2018)... ... September 06, 2018 , ... CTL Medical ... purchase its commercial spine business, which includes its complete portfolio of spine-related patents ... that result from it. The deal will make CTL Medical the world’s exclusive ...
(Date:8/31/2018)... ... 30, 2018 , ... CallTower is pleased to announce Jason Ulm, ... telecommunications experience and over ten years in executive leadership. Prior to joining CallTower, Jason ... early 2018. , In this new role, Jason will manage CallTower’s ...
(Date:8/31/2018)... Calif. (PRWEB) , ... August 30, 2018 , ... ... firm for the life sciences and healthcare industries, has received the 2018 Services Partner ... The award was presented by Box SVP of Business Development and Platform Sales, Niall ...
Breaking Biology News(10 mins):